Clinical Trial Update: Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Vitamin E combined with fruquintinib and tislelizumab in microsatellite-stable metastatic colorectal cancer. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• Tislelizumab (tislelizumab)
• Vitamin E (tocopherol)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma | Phase 2 | Status: RECRUITING